Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutamine synthetase (GS) is an ATP-dependent enzyme that catalyzes the synthesis of glutamine from glutamate and ammonia. This reaction is central to nitrogen metabolism, detoxifying ammonia and regulating glutamate levels. It is crucial for glutamine production, which is essential for various biosynthetic processes. GS activity is tightly regulated and also exhibits 'moonlighting' functions beyond its primary catalytic role. Dysregulation is implicated in neurological disorders and cancer.
Two-step mechanism involving ATP-dependent phosphorylation of glutamate followed by ammonia attack to form glutamine and inorganic phosphate.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutamine Synthetase (GS).